High Hopes for Johnson & Johnson’s Covid Vaccine Have Fizzled in the U.S.

Production problems and a brief pause on its use kept the one-dose vaccine from becoming the game changer that health officials across the country believed it would be.Production problems and a brief pause on its use kept the one-dose vaccine from becoming the game changer that health officials across the country believed it would be.Johnson & Johnson, Coronavirus (2019-nCoV), Vaccination and Immunization, Drugs (Pharmaceuticals), Shutdowns (Institutional), Regulation and Deregulation of Industry, States (US), Rural Areas, Emergent BioSolutions Inc, Factories and Manufacturing, Gorsky, AlexRead More

Leave a Reply

Your email address will not be published.